On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

For 55 years, my mom and I have been at each other — constantly poking the soft spots and picking at scabs. She judged and ...

Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive interim results from its ongoing POLARIS ...

The EMBOLD topline results will be presented at the American Epilepsy Society Annual Meeting at the Georgia World Congress Center, Poster Hall B2, 1.38 from 12:00-2:00 p.m. on Saturday, December 6, ...

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break—when both sides of ...

BASEL, Switzerland and LINCOLNSHIRE, Il., Dec. 2, 2025 /PRNewswire/ -- Vaderis Therapeutics today announced that data from its randomized, double-blind, placebo-controlled, multi-center proof-of-conce ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.